Rhodium-catalyzed asymmetric arylation of N- and O-containing cyclic aldimines: facile and efficient access to highly optically active 3,4-dihydrobenzo[1,4]oxazin-2-ones and dihydroquinoxalinones-Reference-Cited by-同舟云学术

Rhodium-catalyzed asymmetric arylation of N- and O-containing cyclic aldimines: facile and efficient access to highly optically active 3,4-dihydrobenzo[1,4]oxazin-2-ones and dihydroquinoxalinones

Published:2016 Issue:8 Volume:3 Page:944-948
ISSN:2052-4129
Container-title:Organic Chemistry Frontiers
language:en
Short-container-title:Org. Chem. Front.

Author:

Zhang Xu¹²³⁴⁵,Xu Bin¹²³⁴⁵,Xu Ming-Hua⁶⁷⁸⁹⁵

Affiliation:

1. Department of Chemistry

2. Innovative Drug Research Center

3. Shanghai University

4. Shanghai 200444

5. China

6. State Key Laboratory of Drug Research

7. Shanghai Institute of Materia Medica

8. Chinese Academy of Sciences

9. Shanghai 201203

Abstract

A highly enantioselective Rh-catalyzed arylation of benzoxazinones and quinoxalinones with arylboroxines was realized for the first time by employing a simple sulfur-olefin as the ligand.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/QO/C6QO00191B

Reference42 articles.

1. Discovery of a Potent, Non-peptide Bradykinin B1 Receptor Antagonist

2. Synthesis and activity of a new class of pathway-selective estrogen receptor ligands: Hydroxybenzoyl-3,4-dihydroquinoxalin-2(1H)-ones

3. Structure−Activity Relationships of Alkyl- and Alkoxy-Substituted 1,4-Dihydroquinoxaline-2,3-diones: Potent and Systemically Active Antagonists for the Glycine Site of the NMDA Receptor